Trademark Information

Application ID
Status
Date of Application
30 December 2022
Classes
5
Proprietor
102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai 400072
Attorney
Innovative Consultants[21461]
A 4/501, Vaishnavi Park, Shankar Pawshe Road, Kailash Nagar, Kalyan East, Kalyan, Thane, Maharashtra 421306
Type
Word
State
Maharashtra
Country
Filing Mode
e-Filing
IP Office
MUMBAI
Used Since
Valid / Upto
30 December 2032
Description
[Class : 5] Pharmaceuticals And Medical Preparations For Human Beings; Pharmaceutical Preparation To Treat Symptoms Of Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Active Duodenal Ulcer In Adults, Active Benign Gastric Ulcer In Adults, Erosive Esophagitis, Pathological Hypersecretory Conditions And Zollingerā€“Ellison Syndrome; Medication To Reduce Stomach Acid, Risk Reduction Of Nsaid Associated Gastric Ulcer In Adults; Medical Preparations For Eradication Of H. Pylori To Reduce The Risk Of Duodenal Ulcer Recurrence In Adults; Maintenance Of Healing Duodenal Ulcers And Erosive Esophagitis In Adults; Healing Of Non Steroidal Anti Inflammatory DrugsĀ¬ Associated Gastric Ulcer In Adults; Medical Preparations Containing Proton Pump Inhibitor; Medical Preparations Containing Lansoprazole

Documents

Examination Report

Uploaded Documents

1 TM-A(TRADE MARKS APPLICATION) 30 Dec 2022
2 Journal Copy 15 Nov 2023
3 Certificate 07 Jan 2024

Frequently Asked Questions

When was the trademark applied?

The application for Lasopraz was made on 30 December 2022.

Who is the applicant for Lasopraz?

The trademark applicant for Lasopraz is BLISS GVS PHARMA.

In what class is the trademark applied to?

Lasopraz is applied in class(es) 5.

What is the status of the trademark application?

Application for Lasopraz is on Registered stage.

What is the application ID of the trademark?

Application Id allotted to Lasopraz is 5744533.

Who is the trademark agent or attorney?

Trademark agent or attorney for the application is Innovative Consultants.

What is the type of trademark application?

Lasopraz filed with the Intellectual property office as a WORD.